China's Top 10 Ophthalmology Hospitals (2023 Fudan Rankings)

China's ophthalmology field has become a global leader in clinical care, research, and innovation, driven by massive patient demand and technological advancements. According to Nature Index and The Lancet Global Health, China ranks third worldwide in ophthalmology research output as of 2023.

The country excels in several key areas. In myopia prevention and control, initiatives include pioneering outdoor activity campaigns and the use of orthokeratology lenses. In cataract surgery volume, China performs over 10 million procedures annually, the highest number in the world. In AI-driven diagnostics, Alibaba's AI for diabetic retinopathy screening has revolutionized the field. While Western institutions such as the Johns Hopkins Wilmer Eye Institute lead in subspecialties like gene therapy for inherited retinal diseases, China's strengths lie in high-volume surgical efficiency and comprehensive public health initiatives.

Government support and innovation:

Government-funded innovation targets pediatric myopia and age-related macular degeneration (AMD), ensuring continuous, focused progress. Tele-ophthalmology platforms like "Bright Eyes" provide essential diagnostic services to rural areas. Global collaborations with institutions such as the Singapore National Eye Centre and Moorfields Eye Hospital enhance research on glaucoma. Technological advancements play a pivotal role: telemedicine solutions expand the reach of specialists to rural patients, while AI integration leads to more accurate and timely diagnoses.

Top 10 ophthalmology hospitals (2023 Fudan Rankings):

The top hospital scored 11.076 and is ranked number one in Asia for glaucoma and retinal surgery. Key innovations include 3D-printed corneal implants for keratoconus and AI algorithms predicting glaucoma progression with over 95% accuracy. Its core team includes Prof. Liu Yizhi (Director), a world-renowned expert in complex cataract surgery.

The second scored 8.804, specializing in pediatric ophthalmology and ocular oncology. Key doctors include Prof. Wang Ningli (President), a pioneer in angle-closure glaucoma screening, and Dr. Li Qiyuan, focused on ocular trauma and retinal diseases.

The third scored 7.978, with strengths in corneal transplantation and ocular surface reconstruction. Key innovations include bioengineered amniotic membrane grafts for chemical burns; it was the first Chinese hospital to adopt robot-assisted vitrectomy. Its core team includes Prof. Zhou Xingtao, a leading authority in refractive surgery.

The fourth scored 6.630, focused on diabetic retinopathy and telemedicine. Its key doctor, Prof. Yao Ke, developed China's first AI-based diabetic retinopathy grading system.

The fifth scored 5.761 and is home to the WHO Collaborating Centre for Myopia Prevention.

Rankings 6 to 10 (2023):

6. Ninth People's Hospital, Shanghai Jiao Tong University (Shanghai) - 4.065 - Orbital tumor surgery

7. Peking Union Medical College Hospital (PUMCH) (Beijing) - 3.598 - Uveitis and rare diseases

8. Shanghai General Hospital (Shanghai) - 3.152 - Ocular trauma

9. Tianjin Eye Hospital (Tianjin) - 2.283 - Pediatric strabismus

10. Peking University People's Hospital (Beijing) - 1.457 - Dry eye syndrome

The future of ophthalmology in China looks promising. The combination of government support, international collaborations, and innovative practices positions China as a leader in global eye health, with efforts on myopia control and AI-driven diagnostics likely to improve accessibility and treatment outcomes.